• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 231/14 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 231/14

Total number of patents in this class: 1158

10-year publication summary

103
71
93
79
70
76
77
59
46
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bayer Cropscience AG
2138
66
Syngenta Participations AG
3032
60
Theravance Biopharma R&D IP, LLC
517
49
BASF SE
20432
35
BioCryst Pharmaceuticals, Inc.
176
22
Takeda Pharmaceutical Company Limited
2943
20
Orion Corporation
595
19
Syngenta Limited
482
16
Sumitomo Chemical Company, Limited
8988
16
Activesite Pharmaceuticals, Inc.
18
15
AstraZeneca AB
2958
14
KalVista Pharmaceuticals Limited
115
14
Solvay SA
1030
12
sanofi-aventis
393
12
Dow AgroSciences LLC
1238
11
F. Hoffmann-La Roche AG
7942
10
Bayer Intellectual Property GmbH
2569
10
Blade Therapeutics, Inc.
21
10
Research Triangle Institute
408
10
Rezolute, Inc.
25
10
Other owners 727